Search

Search Constraints

You searched for: Author/Creator Cardoso, Fatima

Search Results

53. Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer. (January 2020)

56. Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trial. (April 2022)

57. Second international consensus guidelines for breast cancer in young women (BCY2). (April 2016)

58. Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial. (May 2022)

60. The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge. Issue 10330 (19th March 2022)